Subtype
Hepatocellular Carcinoma
CI-CAN-00002853HCC · LIHCExplore in graph →
693 active trials13 approved drugs9 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00002853HCC · LIHCExplore in graph →
Clinical trials
3,126 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (357)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT01334112 | Study of Axitinib in Patients With Unresectable Hepatocellular Carcinoma(AXITINIB) | completed | Phase 2 | 30 | University Health Network, TorontoOTHER | 1 | Dec 12, 2019 | clinicaltrials |
| NCT01853618 | Tremelimumab With Chemoembolization or Ablation for Liver Cancer | completed | Phase 1 / Phase 2 | 61 | National Cancer Institute (NCI)NIH | 1 | Dec 10, 2019 | clinicaltrials |
| NCT02774187 | Sorafenib Alone Versus Sorafenib Combined With HAIC for Advanced HCC | completed | Phase 3 | 247 | Sun Yat-sen UniversityOTHER | 1 | Dec 5, 2019 | clinicaltrials |
| NCT00908752 | Phase III Trans-Arterial Chemo-Embolization (TACE) Adjuvant HCC(BRISK TA) | completed | Phase 3 | 734 | Bristol-Myers SquibbINDUSTRY | 13 | Dec 2, 2019 | clinicaltrials |
| NCT02643173 | Hepatocellular Carcinoma Recurrence and Anesthesia | completed | — | 259 | Seoul National University Bundang HospitalOTHER | 1 | Nov 22, 2019 | clinicaltrials |
| NCT04172194 | Endoarterial Treatment in Combination With Percutaneous Thermoablation for Medium-sized and Oligonodular Hepatocellular Carcinomas | completed | — | 64 | Centre Hospitalier Universitaire de NiceOTHER | 1 | Nov 21, 2019 | clinicaltrials |
| NCT04161911 | A Study to Assess Overall Survival and Treatment Patterns for Advanced Liver Cancer Participants Who Received Nivolumab Therapy | completed | — | 1,426 | Bristol-Myers SquibbINDUSTRY | 1 | Nov 13, 2019 | clinicaltrials |
| NCT02259647 | Sorafenib Plus Vitamin K1 Versus Sorafenib in Advanced Hepatocellular Carcinoma | completed | N/A | 60 | Institute of Liver and Biliary Sciences, IndiaOTHER | 1 | Oct 28, 2019 | clinicaltrials |
| NCT03162198 | Frequency of Circulating Tumor Cells (CTCs) and Amount of Cell-free DNA (cfDNA) in Cirrhotic Patients With Hepatocellular Carcinoma (HCC) | completed | — | 53 | Institute of Liver and Biliary Sciences, IndiaOTHER | 1 | Oct 23, 2019 | clinicaltrials |
| NCT00844454 | Multi-pronged Ethanol Ablation and Radiofrequency Ablation of Early-stage Hepatocellular Carcinoma(QPEAvsRFA) | completed | N/A | 81 | Sun Yat-sen UniversityOTHER | 1 | Oct 8, 2019 | clinicaltrials |
| NCT02387307 | A Study of rSIFN-co in Subjects With Advanced Solid Tumors(rSIFN-01) | completed | Phase 1 | 42 | Sichuan Huiyang Life Science and Technology CorporationINDUSTRY | 1 | Sep 27, 2019 | clinicaltrials |
| NCT02854839 | A Study of MG4101 (Allogeneic Natural Killer Cell) for Intermediate-stage of Hepatocellular Carcinoma | completed | Phase 2 | 78 | GC Cell CorporationINDUSTRY | 1 | Sep 26, 2019 | clinicaltrials |
| NCT02814461 | The Safety and Maximum Tolerated Dose of Axitinib in Combination With Radiotherapy for HCC | completed | Phase 1 | 9 | Shin Kong Wu Ho-Su Memorial HospitalOTHER | 1 | Sep 23, 2019 | clinicaltrials |
| NCT01850368 | Stereotactic Ablative Radiotherapy for Hepatocellular Carcinoma With Major Portal Vein Invasion | completed | Phase 2 | 35 | Korea Cancer Center HospitalOTHER | 1 | Sep 20, 2019 | clinicaltrials |
| NCT01850667 | Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma | completed | Phase 2 | 74 | Korea Cancer Center HospitalOTHER | 1 | Sep 20, 2019 | clinicaltrials |
| NCT02961998 | Preventive Effect of Celecoxib on Sorafenib-related Hand Foot Syndrome, a Single Center, Randomized Controlled Clinical Trail | completed | Phase 4 | 116 | Sun Yat-sen UniversityOTHER | 0 | Sep 10, 2019 | clinicaltrials |
| NCT01287585 | Ph 3 ADI-PEG 20 Versus Placebo in Subjects With Advanced Hepatocellular Carcinoma Who Have Failed Prior Systemic Therapy(ADI-PEG 20) | completed | Phase 3 | 636 | Polaris GroupINDUSTRY | 6 | Sep 6, 2019 | clinicaltrials |
| NCT03516071 | A Phase 2 Study of Brivanib in Chinese Patients With Previously Treated Advanced HCC | completed | Phase 2 | 90 | Zai Lab (Shanghai) Co., Ltd.INDUSTRY | 1 | Sep 4, 2019 | clinicaltrials |
| NCT01837381 | Transarterial Ethanol Ablation(TEA) for Unresectable Hepatocellular Carcinoma(HCC) | completed | N/A | 200 | Chinese University of Hong KongOTHER | 1 | Sep 3, 2019 | clinicaltrials |
| NCT02395250 | Anti-GPC3 CAR T for Treating Patients With Advanced HCC | completed | Phase 1 | 13 | RenJi HospitalOTHER | 1 | Aug 28, 2019 | clinicaltrials |
| NCT03146234 | CAR-GPC3 T Cells in Patients With Refractory Hepatocellular Carcinoma | completed | N/A | 7 | RenJi HospitalOTHER | 1 | Aug 28, 2019 | clinicaltrials |
| NCT03630068 | Computer-assisted Tumor Ablation for Patients With Liver Cancer | completed | — | 87 | Insel Gruppe AG, University Hospital BernOTHER | 1 | Aug 28, 2019 | clinicaltrials |
| NCT04069416 | Salvage Living Donor Liver Transplantation for HCC Beyond All Criteria Yield Equivalent Results to Milan Criteria | completed | — | 241 | Ain Shams UniversityOTHER | 0 | Aug 28, 2019 | clinicaltrials |
| NCT03212625 | The Effect of Urea Cream on Sorafenib-associated Hand-Foot Skin Reaction | completed | Phase 4 | 288 | Korea University Guro HospitalOTHER | 1 | Aug 22, 2019 | clinicaltrials |
| NCT02635347 | Remote Ischemic Conditioning (RIC) in Recipients of Brain Death Donor Livers - A Feasibility and Safety Study | completed | N/A | 31 | Rutgers, The State University of New JerseyOTHER | 1 | Aug 20, 2019 | clinicaltrials |
| NCT03939975 | Anti-PD-1therapy Combined With Thermal Ablation for Advanced HCC | completed | Phase 2 | 50 | Sun Yat-sen UniversityOTHER | 1 | Aug 19, 2019 | clinicaltrials |
| NCT03995459 | Deportalization, Venous Deprivation, Venous Congestion | completed | — | 12 | University Hospital, MontpellierOTHER | 1 | Aug 12, 2019 | clinicaltrials |
| NCT04015245 | SNMC (Stronger Neo-Minophagen C ) for Acute Hepatitis Post Transarterial Chemoembolization Therapy | completed | Phase 4 | 60 | Chimei Medical CenterOTHER | 1 | Jul 10, 2019 | clinicaltrials |
| NCT01473121 | Hepatocellular Carcinoma Registry for Turkey (3K Trial) | completed | — | 600 | BayerINDUSTRY | 1 | Jul 5, 2019 | clinicaltrials |
| NCT00428220 | A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study. | completed | N/A | 223 | PfizerINDUSTRY | 17 | Jun 27, 2019 | clinicaltrials |
| NCT02372162 | Fingerprint Characterization of Advanced HCC(e:Med-HCC-1) | completed | — | 25 | University Hospital TuebingenOTHER | 1 | Jun 19, 2019 | clinicaltrials |
| NCT00923897 | Palliative Radiotherapy (RT) for Liver Metastases (Mets) and Hepatocellular Carcinoma (HCC)(COLD 4) | completed | Phase 2 | 40 | University Health Network, TorontoOTHER | 1 | Jun 18, 2019 | clinicaltrials |
| NCT02173119 | Can Quantitative MRI After cTACE Help Predict Survival ? | completed | — | 23 | Medical College of WisconsinOTHER | 1 | Jun 10, 2019 | clinicaltrials |
| NCT01126645 | Sorafenib and Micro-therapy Guided by Primovist Enhanced MRI in Patients With Inoperable Liver Cancer(SORAMIC) | completed | Phase 2 | 529 | University of MagdeburgOTHER | 1 | May 31, 2019 | clinicaltrials |
| NCT00901901 | Nexavar-Tarceva Combination Therapy for First Line Treatment of Patients Diagnosed With Hepatocellular Carcinoma(SEARCH) | completed | Phase 3 | 732 | BayerINDUSTRY | 26 | May 30, 2019 | clinicaltrials |
| NCT01008917 | Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma | completed | Phase 1 | 25 | University of California, San FranciscoOTHER | 1 | May 9, 2019 | clinicaltrials |
| NCT00586235 | Registration and Fusion of Real-Time Ultrasound With CT for Lesion Localization and Characterization | completed | — | 80 | Mayo ClinicOTHER | 1 | May 6, 2019 | clinicaltrials |
| NCT02471313 | Integrated Imaging Strategy to Phenotype Progression of Liver Tumors During and After Chemoembolization | completed | Phase 2 | 3 | National Institutes of Health Clinical Center (CC)NIH | 1 | Apr 23, 2019 | clinicaltrials |
| NCT03300414 | Biologic Basis of Liver Cancer From Chronic Hepatitis B | completed | — | 2 | University of California, DavisOTHER | 1 | Apr 11, 2019 | clinicaltrials |
| NCT00397540 | The Effect of Viral Load on Intrahepatic Recurrence in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC) | completed | N/A | 145 | Seoul National University HospitalOTHER | 1 | Mar 18, 2019 | clinicaltrials |
| NCT01952353 | Preoperative Transarterial Chemoembolization for Resectable HCC With Portal Venous Invasion | completed | Phase 4 | 330 | Sun Yat-sen UniversityOTHER | 1 | Mar 7, 2019 | clinicaltrials |
| NCT01229839 | Chemoembolization With or Without Mixing the Chemotherapy With Lipiodol for Unresectable HCC | completed | Phase 3 | 668 | Sun Yat-sen UniversityOTHER | 1 | Mar 6, 2019 | clinicaltrials |
| NCT01259414 | Comparison of Two Solvents Used With Chemotherapy Agent for Transarterial Chemoembolization of Hepatocellular Carcinoma | completed | Phase 3 | 812 | Sun Yat-sen UniversityOTHER | 1 | Mar 6, 2019 | clinicaltrials |
| NCT02981498 | Phase II Trial of Sorafenib Combined With Concurrent HAIC for Hepatocellular Carcinoma | completed | Phase 2 | 35 | Sun Yat-sen UniversityOTHER | 1 | Mar 6, 2019 | clinicaltrials |
| NCT02151864 | LDE225 in Patients With Advanced or Metastatic Hepatocellular Carcinoma and Child-Pugh A/B7 Cirrhosis | completed | Phase 1 | 9 | Jason K. Sicklick, M.D.OTHER | 1 | Mar 5, 2019 | clinicaltrials |
| NCT02587793 | Primary Culture of Residual Specimens Obtained From Aspiration of Hepatic Tumor to Predict the Prognosis of the Patients | completed | — | 208 | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | Feb 27, 2019 | clinicaltrials |
| NCT02425605 | Efficacy of Localized Concurrent Chemo-radiation Therapy and Sorafenib Sequential Therapy in Advanced Hepatocellular Carcinoma | completed | Phase 2 | 47 | Yonsei UniversityOTHER | 1 | Feb 25, 2019 | clinicaltrials |
| NCT03852238 | Risk Factors of Hepatocellular Carcinomas Developed on Non-fibrotic Liver: Case-control Study (NoFlic Study)(NoFlic) | completed | — | 283 | University Hospital, BordeauxOTHER | 1 | Feb 25, 2019 | clinicaltrials |
| NCT01619475 | Adult-to-Adult Living Donor Transplant Cohort Study(A2ALL-2) | completed | — | 1,871 | Arbor Research Collaborative for HealthOTHER | 2 | Feb 8, 2019 | clinicaltrials |
| NCT00441376 | A Study of ThermoDox™ in Combination With Radiofrequency Ablation (RFA) in Primary and Metastatic Tumors of the Liver | completed | Phase 1 | 30 | ImunonINDUSTRY | 1 | Feb 7, 2019 | clinicaltrials |
Data updated 23 days agoSource updated Dec 12, 2019source: clinicaltrials